SOBI:STO
Swedish Orphan Biovitrum AB (publ)
SEKÂ 482.60
arrow_upward
+1.09%(+5.20) 1D
Nov 4, 5:29:50 PM GMT+1 · SEK
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for SOBI...
Open
SEKÂ 478.40
High
SEKÂ 482.60
Low
SEKÂ 474.20
Mkt. cap
172.60B
Avg. vol.
331.30K
Volume
399.97K
P/E ratio
25.63
52-wk high
SEKÂ 492.00
52-wk low
SEKÂ 314.40
EPS
SEKÂ 18.83
Shares outstanding
357.64M
No. of employees
2K
Open
SEKÂ 478.40
High
SEKÂ 482.60
Low
SEKÂ 474.20
Mkt. cap
172.60B
Avg. vol.
331.30K
Volume
399.97K
P/E ratio
25.63
52-wk high
SEKÂ 492.00
52-wk low
SEKÂ 314.40
EPS
SEKÂ 18.83
Shares outstanding
357.64M
No. of employees
2K
News stories
From web sources and news partners
富途牛牛
·
6 minutes ago
data center stocks are sold off, CoreWeave drops 10%; the Golden Dragon Index rises 3%
ChartMill
·
38 minutes ago
S&P 500 After-Hours Losers: FICO, EXPE, QCOM Lead Postmarket Declines
TradingView
·
1 hour ago
The Dow Jones Index Closes 3.05% Higher
Investing.com
·
2 hours ago
S&P upgrades KLA to ’A’ as AI chip demand bolsters scale and balance sheet
Profile
Sobi - Swedish Orphan Biovitrum AB is an international biopharmaceutical company focused on rare diseases. The company develops, commercializes, and delivers therapies in the fields of haematology, immunology and specialty care. Headquartered in Stockholm, Sweden, with major hubs in Basel, Switzerland, and Waltham, USA.
Sobi has a global presence in approximately 30 countries and provides medicines to patients in many more around world. The company develops treatments for patients living with complex and chronic rare conditions and maintains a pipeline of development and lifecycle management programs focused on advancing innovative therapies for diseases with significant unmet medical needs. Wikipedia
About Swedish Orphan Biovitrum AB (publ)